The Tolerogenic Peptide, hCDR1, Down-Regulates the Expression of Interferon-α in Murine and Human Systemic Lupus Erythematosus

BACKGROUND: The tolerogenic peptide, hCDR1, ameliorated manifestations of systemic lupus erythematosus (SLE) via the immunomodulation of pro-inflammatory and immunosuppressive cytokines and the induction of regulatory T cells. Because type I interferon (IFN-α) has been implicated to play a role in S...

Descripción completa

Detalles Bibliográficos
Autores principales: Sthoeger, Zev, Zinger, Heidy, Sharabi, Amir, Asher, Ilan, Mozes, Edna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610660/
https://www.ncbi.nlm.nih.gov/pubmed/23555966
http://dx.doi.org/10.1371/journal.pone.0060394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610660/
https://www.ncbi.nlm.nih.gov/pubmed/23555966
http://dx.doi.org/10.1371/journal.pone.0060394

Ejemplares similares